HB 1249 prohibits certified recovery residences in Maryland from refusing services to individuals receiving medication-assisted treatment (MAT) for opioid use disorder or requiring them to stop or change their MAT as a condition for housing. The bill amends certification standards for recovery residences (which provide non-clinical housing for people with substance use disorders) to ensure credentialing entities cannot allow such discrimination. It directly affects certified recovery residences and individuals using MAT for opioid addiction, requiring certification rules to explicitly ban these practices. The law takes effect October 1, 2026, and applies only to opioid use disorder treatment under MAT.
HB 1076 requires all public senior higher education institutions (like University System of Maryland schools) and community colleges in Maryland to annually report on student access to over-the-counter contraception to the Maryland Higher Education Commission. Community colleges must provide students with access to all FDA-approved over-the-counter contraception methods through campus health centers, retail locations, vending machines, or other accessible campus channels. Institutions must submit reports detailing access methods, availability, and student consultation, with the Commission then reporting aggregated data to the General Assembly each year. This bill directly affects campus health services and student access at public colleges, effective July 1, 2026.
HB 457 requires all Maryland colleges and universities to provide free tampons and pads in every restroom by August 1, 2028. This applies to every public and private institution of higher education in the state, directly affecting students, staff, and faculty who use campus restrooms. The bill mandates that institutions supply size-appropriate products without cost, ensuring accessibility for individuals who menstruate. The requirement takes effect July 1, 2026, with full implementation due by the 2028 deadline.
HB 625 shifts responsibility for collecting fees from research facilities to the Maryland Department of Agriculture, replacing the current system under the Department of Health. It requires facilities submitting USDA Form 7023 (for animal testing) to pay annual contributions based on animal count: $5,000 for ≤100 animals, $10,000 for 101-500, $55,000 for 501-5,000, and $75,000 for over 5,000. Funds collected will support the Human-Relevant Research Fund established under Maryland’s Economic Development Article. The bill repeals existing health code provisions and creates new agriculture code sections for this fee structure, effective October 2026.
SB 792 requires the State Health Services Cost Review Commission to create and publish a model policy for hospitals regarding immigration enforcement actions. It also mandates that certain hospitals in Maryland develop their own policies based on this model. The bill amends specific sections of Maryland's health code to implement these requirements, focusing on standardizing how hospitals address immigration enforcement within their facilities. This directly affects designated hospitals by making written policies on immigration enforcement a formal requirement.
HB 1109 creates the Maryland Medical Reserve Corps, a statewide volunteer network for emergencies like disease outbreaks or disasters, managed by the Maryland Department of Health. It requires the Department to notify county health officers about procurement opportunities for electronic health records systems, allowing counties to join without state approval if fully funded locally. The bill establishes a Public Health Workforce Development Fund (using interest earnings and transfers from another fund) and mandates the Department of Legislative Services to assess health equity impacts of new legislation. These changes directly affect county health departments, the Department of Health, and public health workforce planning.
HB 1367 establishes a Commission on Re-Imagining Health Care in Maryland to study and recommend changes for a new statewide healthcare system. The commission, composed of 20 appointed members including state officials, healthcare providers, insurers, county representatives, and community members, will examine how healthcare is delivered in other regions and address issues like provider shortages, cost balancing, and system integration. It will specifically study how to create a patient-centered system covering all health needs, eliminate access barriers, and ensure financial sustainability for all Maryland residents. The commission’s final recommendations, due by 2028, would guide potential future policy changes but do not enact any immediate healthcare reforms.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
SB 439 prohibits Maryland fire and rescue public safety employers from taking negative employment actions (like firing or denying promotions) against employees who use medical cannabis, provided the employee has a valid medical cannabis certification under state law. It amends existing Maryland law to explicitly add this protection for public safety workers, aligning with current medical cannabis certification requirements. The bill does not change how medical cannabis is certified but ensures these employees cannot face discrimination solely for using cannabis legally under the state program. This applies to all fire and rescue employees who meet the state's medical cannabis eligibility criteria.
